Search Results for: doudna

Why UC Berkeley deserves the main CRISPR patent

statment_gene_editing-tech

Some months back a USPTO court issued a ruling that most interpreted as meaning the Broad Institute had won the so-called ‘CRISPR patent battle’ in the U.S. and that UC Berkeley, Jennifer Doudna, and Emmanuelle Charpentier had lost. Now this week Berkeley has appealed that ruling. It seems the odds are against Berkeley prevailing in its appeal, but frankly …

Why UC Berkeley deserves the main CRISPR patent Read More »

Does Word Cloud of Lander’s Heroes of CRISPR Text Suggest Bias?

Lander-cloud-2

Eric Lander’s recent piece in Cell on The Heroes of CRISPR has sparked strong reactions that are mostly critical and have argued that the article is biased. I’m going to weigh in with my own thoughts at some point later, but I thought it would be interesting to try a word cloud-based text mining of the Lander …

Does Word Cloud of Lander’s Heroes of CRISPR Text Suggest Bias? Read More »

Patent expert weighs in on CRISPR dispute between UC & Broad

CRISPR-patent-dispute

The patent dispute on CRISPR between UC/Jennifer Doudna and The Broad/Feng Zhang has been the subject of major attention including in a recent piece on Stanford Center for Law & Biosciences Blog. There is a lot of confusion over this important CRISPR dispute so I turned to a patent expert for their take on this via an interview …

Patent expert weighs in on CRISPR dispute between UC & Broad Read More »

Cool biomed blogs you may not heard of: a drugmonkey, a med student, #CRISPR, & more

Fiona-Scott

Science blogging is somewhat of a communal exercise. At least, it should be and cool biomed blogs are a great community. One of the most invigorating aspects of blogging is finding new blogs that are worthwhile and edgy. Below I list some of my recommendations for blogs that you might not be familiar with, but …

Cool biomed blogs you may not heard of: a drugmonkey, a med student, #CRISPR, & more Read More »

New #CRISPR updates: Editas to go public, patent issues, dragons & more

CRISPR-dragon

A lot has been going on in the CRISPR world. Here are some key CRISPR updates. Editas has filed the paperwork on the road to going public as a company. Such an IPO, should it come to fruition, could raise billions of dollars. Will the other CRISPR companies like Caribou and CRISPR Therapeutics follow suit? Simplistically, …

New #CRISPR updates: Editas to go public, patent issues, dragons & more Read More »

Live Blogging #GeneEditSummit Day 1 Post #2: State of the Science, #CRISPR

Human-gene-editing-science-session-small

Now we hear from the scientists on the front lines of CRISPR, covered in this post #2 of the Human Gene Editing Meeting. You can read Post #1 here. Jennifer Doudna starts off the big human gene editing science session on the current state of the human gene editing science and CRISPR. She gave an …

Live Blogging #GeneEditSummit Day 1 Post #2: State of the Science, #CRISPR Read More »

Live Blogging NAS Human Gene Editing Summit: #GeneEditSummit

Jennifer-Doudna

The National Academy of Sciences (NAS)  summit on Human Gene Editing will begin in a few days on December 1 in Washington, D.C. This summit is in part the extension of discussions that started at a more informal meeting on CRISPR earlier this year in Napa organized by Jennifer Doudna and colleagues. The NAS meeting …

Live Blogging NAS Human Gene Editing Summit: #GeneEditSummit Read More »

NAS Meeting on Human Germline Modification Taking Shape

NAS-CRISPR3

The US National Academy of Sciences (NAS) will hold a meeting on heritable human germline modification on December 1-3, 2015 in Washington, D.C. Invitations to the NAS meeting to individuals starting going out last week. The upcoming NAS meeting seeks to address these issues and discuss the possibility of a moratorium on clinical use of …

NAS Meeting on Human Germline Modification Taking Shape Read More »

Perspectives on Hinxton Human Germline Modification Statement

Hinxton-Group

The international stem cell policy and ethics think tank, the Hinxton Group, weighed in yesterday on heritable human genetic modification with a new policy statement. The Hinxton statement is in many ways in agreement with the Baltimore, et al. Nature paper proposing a “prudent path forward” for human germline genetic modification, which came out of …

Perspectives on Hinxton Human Germline Modification Statement Read More »